|Videos|July 23, 2021

Can We Provide Tailored Care for Homeless HIV Patients?

A discussion as to why people with unstable housing living with HIV may not prefer telehealth versus consistent in-person care.

Preferred HIV treatment among patient populations is diversified; among housing-compromised persons, even more factors come into play.

As described in a new study presented at the International AIDS Society (IAS) 2021 Conference on HIV Science last week, homeless or people with unstable housing living with HIV provided varied feedback on care models preference, physician continuity needs, telehealth resourcing, and incentive-based care.

The findings, presented by Elizabeth Imbert, MD, MPH, associate professor at UCSF and clinical lead of the trial’s POP-UP Program at Ward 86 in San Francisco, suggest the need for more focused care toward the homeless HIV population.

In the second segment of an interview with Contagion during IAS 2021, Imbert explained the observed populations’ HIV care preference particularities, such as that with Telehealth.

“I think one of the take-home messages from this is that folks who are homeless or unstably housed with HIV, during COVID-19, did not prefer telehealth, even when we said, ‘Someone can come to you,’” Imbert said. “To me, as a provider, that says we should keep our doors open, because these folks are vulnerable.”

Imbert also discussed the need for personable, tailored care from consistent caregivers dedicated to this HIV population.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.